The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Exacerbation of ulcerative colitis after rituximab salvage therapy
Abstract
BACKGROUND: B-cells are considered to play a pathogenic role in human ulcerative colitis (UC) by producing autoantibodies that cause epithelial cell damage. Here we report on a patient with intractable UC who suffered from a severe exacerbation of UC after salvage therapy with rituximab, a B-cell-depleting anti-CD20-antibody. METHODS: A 58-year-old patient with active long-standing UC and unresponsiveness or adverse events to mesalamine, corticosteroids, azathioprine, methotrexate, infliximab, leukapheresis, mycophenolate mofetil, and adalimumab received 375 mg/m(2) rituximab. RESULTS: A severe exacerbation of UC activity was noted upon therapy that required hospitalization. Subsequent studies showed a complete depletion of CD20-positive mucosal B-cells associated with a suppression of local IL-10 production. CONCLUSIONS: In contrast to rheumatoid arthritis patients, rituximab had deleterious effects in our UC patient by blocking IL-10 producing B-cells. Our data suggest an important anti- rather than proinflammatory role of B-cells in UC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,902
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Self-citationThe role of Th1/Th2 polarization in mucosal immunity
Neurath, M. F., Finotto, S., & Glimcher, L. H. (2002) · Nature Medicine · doi:10.1038/nm0602-567 · Cited by 623
Self-citationSustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes
Edwards, J. C. W., & Cambridge, G. (2001) · Rheumatology · doi:10.1093/rheumatology/40.2.205 · Cited by 523
Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties
Brandtzaeg, P., & Johansen, F. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00283.x · Cited by 447
Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.
Macpherson, A., Khoo, U. Y., Forgacs, I., Philpott-Howard, J., & Bjarnason, I. (1996) · Gut · doi:10.1136/gut.38.3.365 · Cited by 443
Suppressive Role of B Cells in Chronic Colitis of T Cell Receptor α Mutant Mice
Mizoguchi, A., Mizoguchi, E., Smith, R. N., Preffer, F. I., & Bhan, A. K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1749 · Cited by 345
Regulatory role of mature B cells in a murine model of inflammatory bowel disease
Mizoguchi, E., Mizoguchi, A., Preffer, F. I., & Bhan, A. K. (2000) · International Immunology · doi:10.1093/intimm/12.5.597 · Cited by 206
Wei, B., Velazquez, P., Turovskaya, O., Spricher, K., Aranda, R., Kronenberg, M., Birnbaumer, L., & Braun, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409449102 · Cited by 176
Wirtz, S. J., & Neurath, M. F. (2000) · International Journal of Colorectal Disease · doi:10.1007/s003840000227 · Cited by 150
Self-citationB Cell Developmental Requirement for the G α i2 Gene
Dalwadi, H., Wei, B., Schrage, M. I., Su, T. T., Rawlings, D. J., & Braun, J. G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.1707 · Cited by 128
Olson, T. S., Bamias, G., Naganuma, M., Rivera–Nieves, J., Burcin, T. L., Ross, W., MORRIS, M. A., Pizarro, T. T., Ernst, P. B., Cominelli, F., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20855 · Cited by 107
Cited by
Yanaba, K., Bouaziz, J.-D., Haas, K. M., Poe, J. C., Fujimoto, M., & Tedder, T. F. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.017 · Cited by 1,238
Danese, S., & Fiocchi, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1102942 · Cited by 1,102
Shen, P., Roch, T., Lampropoulou, V., O’Connor, R. A., Stervbo, U., Hilgenberg, E., Ries, S., Dang, V. D., Jaimes, Y., Daridon, C., et al. (2014) · Nature · doi:10.1038/nature12979 · Cited by 1,048
Self-citationGuidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
Matsushita, T., Yanaba, K., Bouaziz, J.-D., Fujimoto, M., & Tedder, T. F. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36030 · Cited by 913
Metadata
- Authors
- Goetz, M., Atreya, R., Ghalibafian, M., Galle, P. R., & Neurath, M. F.
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-11
- Volume
- 13
- Issue
- 11
- Pages
- 1365-1368
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W2104725915
- Cited by
- 268
- References
- 14
- FWCI
- 8.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.